Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)

Azim M Mohamedali, PhD, Joop Gaken, PhD, Momin Ahmed, MD PhD, Austin Kulasekararaj, Alexander E Smith, PhD, Farook Malik, PhD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 4655.

https://doi.org/10.1182/blood.V124.21.4655.4655

Published: 2014

Journal Articles

Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with Haematological and Clinical Features

Shreyans A Gandhi, MD DNB, MRCP, FRCPath, Jie Jiang, PhD, Nana benson-Quarm, Syed A Mian, Steve Best, PhD, Austin Kulasekararaj, Judith C Marsh, MD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 2935.

https://doi.org/10.1182/blood.V124.21.2935.2935

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Anjum Bashir Khan, MBChB, MRCP, Alesia Abigael Hunt, MBChB, Victoria T Potter, MD FRCPA, FRACP, Shireen Kassam, MBBS, Deborah Yallop, MB, BS, BSc.(hons), MRCP, FRCPath, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Stephen Devereux, MD PhD FRCPath, Ghulam Mufti, MD DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Robert E. Marcus, MBBS, FRCP, FRCPath

Blood (2014) 124 (21): 1197.

https://doi.org/10.1182/blood.V124.21.1197.1197

Published: 2014

Journal Articles

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Anita Sarma, MBChB, BSc, MRCP, Victoria T Potter, MD FRCPA, FRACP, Jennifer Clay, BM BS, FRACP, FRCPA, Donal McLornan, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Kavita Raj, Judith C. W. Marsh, Austin Kulasekararaj, Antonio Pagliuca, MD FRCP, FRCPath, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 1236.

https://doi.org/10.1182/blood.V124.21.1236.1236

Published: 2014

Journal Articles

Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome & Acute Myeloid Leukaemia

Sneha Shinde, Azim M Mohamedali, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 3555.

https://doi.org/10.1182/blood.V124.21.3555.3555

Published: 2014

Journal Articles

RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis

Heba A Alkhatabi, MSc, Joop Gaken, PhD, Austin Kulasekararaj, Shengjiang Tan, PhD, Farooq Malik, BSc, PhD, Alan John Warren, PhD FRCP, FRCPath, FMedSci, Thomas Seidl, David C Darling, PhD, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 1895.

https://doi.org/10.1182/blood.V124.21.1895.1895

Published: 2014

Journal Articles

Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)

Pierre Fenaux, MD, PhD, Aristotles Giagounidis, MD, Odile Beyne-Rauzy, MD, PhD, Ghulam Mufti, MD, DM, FRCP, FRCPath, Moshe Mittelman, MD, Petra Muus, MD, PhD, Peter te Boekhorst, MD, PhD, Guillermo Sanz, MD, PhD, Mario Cazzola, MD, Jay Backstrom, MD, Tommy Fu, PhD, Eva Hellström-Lindberg, MD, PhD

Blood (2010) 116 (21): 4027.

https://doi.org/10.1182/blood.V116.21.4027.4027

Published: 2010

NARROW

Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)

Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with Haematological and Clinical Features

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome & Acute Myeloid Leukaemia

RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis

Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)

Email alerts

ASH Publications

American Society of Hematology

Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)

Telomere Gene Complex Mutations Are Frequently Found with Shortened Telomeres in Bone Marrow Failure Syndromes and Idiopathic Pulmonary Fibrosis; Correlation with Haematological and Clinical Features

Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Mutation and Expression Analysis of Jumonji Genes in Myelodysplastic Syndrome & Acute Myeloid Leukaemia

RPL27A Is a Target for Mir-595 and Contributes to Myelodysplastic Phenotype through Ribosomal Dysgenesis

Prognostic Factors of Long-Term Outcomes In Low- or Int-1-Risk MDS with del5q Treated with Lenalidomide (LEN): Results From a Randomized Phase 3 Trial (MDS-004)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only